Dr. Melissa Carpenter becomes ElevateBio’s chief scientific officer of regenerative medicine

ElevateBio appointed Melissa Carpenter, PhD, as chief scientific officer of regenerative medicine Dec. 9.

Advertisement

Four things to know:

1. Dr. Carpenter will aim to forge partnerships with developers of stem-cell based regenerative therapies to expand ElevateBio’s portfolio of companies.

2. She was named as inventor on 34 issued U.S. patents and more than 50 peer reviewed publications in the stem cell field.

3. Most recently, Dr. Carpenter was vice president of research and development at NovoCell, where she brought stem cell research programs to preclinical development.

4. She has more than 25 years of experience in the development of cell therapies using human adult and pluripotent stem cells.

More articles on biologics:
3 orthopedic surgeons to expand services at new Iowa facility
2 recent value-based partnerships for orthopedic procedures
DePuy Synthes recalls devices used in spine fixation system: 6 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

  • Regenerative medicine company Auragens has opened an orthobiologics division.  Orthopedic surgeon Abdiel Ortiz, MD, will lead the new division, which…

  • So far this year, medtech companies and academic institutions are making key strides in spine biologics. From new product launches…

Advertisement

Comments are closed.